DURALOCK-C
Trisodium Citrate catheter lock solution
DuraLock-C™: Trisodium citrate - Duralock catheter lock solution reduces infections and thrombosis catheter related, during dialysis and hospitalization. Pre-filled syringes, packaged in fully sterile sets and available in 3 different concentration: 46.7%, 30% e 4%.
Register and download the brochureRequest technical information
DuraLock-C™ - Trisodium citrate solution in water, is the most effective catheter lock solution for CVCs to prevent:
- Clotting / Biofilm
- Infections
Wide range of product
In order to fulfill customer needs, DuraLock-C™ is available in 3 different concentration:
- Duralock-C 46.7%
- Duralock-C 30%
- Duralock-C 4%

WHY DURALOCK-CTM?
- Strong antithrombotic
- No systemic and non-toxic effects
- Prevents biofilm formation
- Broad-spectrum anti-bacterial effect
- No development of drug-resistant bacteria
- Less catheter infections
- Less coagulation in the catheters
- Less use of Urokinase and antibiotics
- Less waiting time (start of treatment)
- Less flow issues
- Less hospitalization
- Less interruption of dialysis treatments
Effective Packaging
- PRE-FILLED SYRINGES: each set include a pair of 3 ml syringe -arterial and venous; each syringe contains 2.5 ml of product.
- Both syringes are luer-type and are packaged in a fully sterile Tyvek® bag.
-
The completely sterile pair of syringes reduces the risk of nosocomial infections compared to the classic vial packaging.

References
(1) Ash SR, Mankus RA, Sutton JM, Criswell RE, Crull CC, Velasquez KA, Smeltzer BD, Ing TS: Concentrated sodium citrate (23%) for catheter lock. Hemodial Int 4: 22-31, 2000
(2) Weijmer MC, Debets-Ossenkopp YJ, van de Vondervoort FJ, ter Wee PM: Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 17:2189-2195, 2002
(3) Bayés B, Bonal J, Romero R: Sodium citrate for filling haemodialysis catheters. Nephrol Dial Transplant 14: 2532-2533, 1999
(4) Weijmer MC, et al: Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J. Am. Soc. Nephrol., 16: 2769 – 2777, 2005
To download the data sheet, you need to access the restricted area:
Not registered?
Register nowWHAT ARE YOU LOOKING FOR?
-
Epidural Anesthesia EpiFaith® Syringe Patient Temperature Management OR Water Warming Equipment Water Hyper-Hypothermia Equipment Esophageal cooling device Cooling Pads Air Hyperthermia Equipment Airway Management TCI - Total Control Introducer IS3-L video laryngoscope IS3-R rigid video laryngoscope I-Workstation ™ Tracheotec® Duravent® Duratwix® Duracuff® Spiraflex® Hemostatic devices GuardaCare® OneStop™ Vascular Hemodynamic Monitoring Non-Invasive & Continuous Hemodynamic Monitoring Thermodilution Catheters Noninvasive Hemodynamic Monitoring - CNAP Catheters Locking Solutions DURALOCK-C A better way to manage lines connections Yewtwist Esophageal pressure monitoring NutriVent™ OptiVent™ DVT prevention devices Fitlegs® AES Grip Fitlegs® AES Fitlegs® Class 2 Fitlegs® geko
CLINICAL SPECIALTIES SEDA
REGISTER TO GET MORE TECHNICAL INFORMATION!
Register to get access to the complete and detailed descriptions of our products.
REGISTER NOW